OS | DFS | |||||||
---|---|---|---|---|---|---|---|---|
Variable | Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | ||||
HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
Gender (female) | 0.832(0.290 ~ 2.387) | 0.732 | 0.617(0.216 ~ 1.761) | 0.367 | ||||
BMI (< 20 kg/m2) | 1.666(0.798 ~ 3.477) | 0.174 | 1.732(0.860 ~ 3.488) | 0.124 | ||||
ypTNM stage (advanced) | 2.708(1.276 ~ 5.746) | 0.009 | 1.810(0.773 ~ 4.242) | 0.172 | 2.622(1.284 ~ 5.354) | 0.008 | 1.939(0.874 ~ 4.301) | 0.104 |
Pathological partial response | 3.142(1.333 ~ 7.408) | 0.009 | 1.438(0.512 ~ 4.043) | 0.490 | 3.127(1.342 ~ 7.289) | 0.008 | 1.631(0.624 ~ 4.262) | 0.318 |
Pre-nCRT SUVmax (≥ 12) | 1.181(0.576 ~ 2.422) | 0.650 | 1.291(0.650 ~ 2.565) | 0.466 | ||||
Post-nCRT SUVmax (≥ 3) | 5.051(1.906 ~ 13.385) | 0.001 | 3.665(1.308 ~ 10.270) | 0.013 | 4.165(1.694 ~ 10.237) | 0.002 | 3.417(1.327 ~ 8.794) | 0.011 |
ΔSUV ratio (< 0.8) | 3.748(1.128 ~ 12.454) | 0.031 | 1.559(0.410 ~ 5.925) | 0.514 | 2.399(0.837 ~ 6.878) | 0.103 |